65
Participants
Start Date
December 1, 2021
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Carbon dioxide breathing
Hypercapnic (5% carbon dioxide) air will be administered before and after intra-nasal insulin exposure.
Neurovascular Coupling
Participants will be asked to repeatedly open and close their eyes. With eyes open, participants will focus on a visual image. This will be done before and after intra-nasal insulin exposure.
Human insulin
Participants will be administered human insulin (160 IU) as a bolus using an intra-nasal device.
University of Missouri, Columbia
University of Missouri-Columbia
OTHER